Tracking symptoms and activity in myeloproliferative neoplasms
Part of Blood & lymphatic clinical trials.
This study uses a smartphone app and a wearable watch to track your symptoms and daily activity. The information may help doctors better understand and manage MPN, and could lead to improved care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a myeloproliferative neoplasm (MPN)
- You live in the UK
- You are 18 years or older
- You can converse comfortably in English
- You have access to a smartphone or mobile phone
- You are able to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a type of white blood cell (monocyte) affects myeloproliferative neoplasms, a group of blood cancers. It aims to help doctors better understand these diseases and improve treatment.
This trial is testing a digital lifestyle app designed to help people with myeloproliferative neoplasms (MPNs) manage their health and wellness. By using the app, you may get support in tracking symptoms, lifestyle habits, and connecting with resources that could improve your quality of life.
This study uses wearable technology (like smartwatches) to monitor your health and quality of life while you receive treatment for blood cancers like myeloma or myelodysplastic syndromes. The goal is to help doctors better understand how blood transfusions and other supportive care affect how you feel day-to-day.
This study uses your self-reported symptoms (PRO) and wearable/device data to help improve care for people with relapsed multiple myeloma who are starting new treatment. It may help by providing insights about how you’re doing during therapy—without changing your cancer treatment in a study-specific way.
This trial tests if a wearable device paired with a smartphone app can help monitor symptoms in cancer survivors. The goal is to improve how we track and manage symptoms during and after treatment.
This study uses a smartphone or web app to track infections and quality of life in people with multiple myeloma or chronic lymphocytic leukemia who have a weakened immune system. The goal is to create a better screening tool for infections and understand how the disease and treatment affect daily life.
Hear when a new Myeloproliferative Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.